Biosimilar Insights

  1. Facts About AAV Producer Cell Lines 8/8/2025

    Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.

  2. Productivity In mAb Capture 7/31/2025

    Discover how optimizing monoclonal antibody capture chromatography—especially resin selection—can dramatically improve cost efficiency, scalability, and productivity in therapeutic antibody manufacturing.

  3. Balancing Protein A Resin Cost, Performance, And Productivity 7/31/2025

    Optimizing input parameters like DBC, flow rate, and resin durability is key to boosting productivity in downstream bioprocessing. Discover how to tailor resin choices to meet your specific process requirements.

  4. Solid Formulation: Spray Drying Process 7/24/2025

    Transform your pharmaceutical development with an innovative spray drying technology that enhances API solubility to improve drug bioavailability and formulation performance.

  5. Overcoming Gene Therapy Cost Roadblocks On The Path To Patients 7/23/2025

    Viral vector-based gene therapies are expanding beyond rare diseases to treat larger populations. Discover how innovations in manufacturing are making these life-changing treatments more accessible.

  6. Viral Gene Therapy: Reducing Costs To Improve Patient Access 7/23/2025

    Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.

  7. Together, Let's Sail Toward Success 7/23/2025

    Explore the promise and complexity of gene therapy and see how Cytiva empowers scientists to overcome challenges and accelerate life-changing treatments from lab to patient.

  8. Non Animal Origin Squalene For High-Risk Applications 7/21/2025

    Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.

  9. 3 Key Considerations In Gene Therapy Manufacturing 7/15/2025

    Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.

  10. Millipore Sigma Bio-Expo Live June 2025: Downstream Bioprocessing 7/3/2025

    Learn about the development and advantages of a new affinity ligand platform. It provides versatile, single-step purification for recombinant proteins and virus particles, enhancing yield and purity.